Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8095539
Reference Type
Journal Article
Title
Antioxidant and antiarrhythmlc activity of carvedilol vs anaprilin in patients with coronary disease
Author(s)
Vasilyev, AP; Streltsova, NN; Gorbunova, TY; Maltseva, IA; Zykova, EL
Year
2001
Is Peer Reviewed?
1
Journal
Terapevticheskii Arkhiv
ISSN:
0040-3660
Volume
73
Issue
10
Page Numbers
65-67
Language
Russian
Abstract
Aim. To examine antioxidant and antiarrhythmic activity of carvedilol vs that of standard beta-blocker anaprilin in coronary patients with low left ventricular ejection fraction (LVEF). Material and methods. The cross-over trial enrolled 50 coronary male patients with LVEF under 45%. Before and after treatment with carvedilol and anaprilin, measurements were made of blood dienic conjugates and malonic dialdehyde, 24-h ECG monitoring was performed. Results. The antioxidant activity of antiarrhythmic effect of carvedilol was significantly higher than that of anaprilin. A correlation was discovered between the number of extrasystoles and blood levels of dienic conjugates. Conclusion. Marked antioxidant activity of carvedilol as well as reduced myocardial energy consumption resultant from hemodynamic cardiac unloading due to block of alpha-adrenoreceptors contribute to carvedilol additional antiarrhythmic effect.
Keywords
Arrhythmia; Carvedilol; Ischemic heart disease; Lipid peroxidation
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity